Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life

Medical Xpress

A combination of CBD and THC rapidly and significantly reduces agitation in hospice-eligible people with dementia, suggest top-line results from the phase 2 LiBBY (Life's End Benefits of cannaBidiol and tetrahYdrocannabinol) clinical trial.

The findings were reported for the first time at the Alzheimer's Association International Conference 2026 in London and online. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

Results from trial show THC/CBD combination significantly reduces agitation for people with dementia at end of life

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

AI technology sees through leaves to transform horticulture

Indigenous Australians want to use cultural medicines more often, but access remains difficult

Carbon management revives CCS in Germany as safeguards steadily weaken

Medical Xpress의 다른 기사

Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach

Few young adults receive palliative care as part of advanced cancer treatment

Impaired functioning of the brain's clearance system could be involved in various neurodegenerative diseases